National Heart, Lung, and Blood Institute; Amended Notice of Meeting, 69213 [2023-22099]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 192 / Thursday, October 5, 2023 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Heart, Lung,
and Blood Advisory Council, October
24, 2023, 9 a.m. to October 24, 2023, 5
p.m., National Institutes of Health,
Rockledge I, 6705 Rockledge Drive,
Bethesda, MD 20892 which was
published in the Federal Register on
September 14, 2023, FR Doc. 2023–
19906, 88 FRN 63116.
This notice is being amended to
change the meeting time for National
Heart, Lung, and Blood Advisory
Council closed session on October 24,
2023 from 9 a.m. to 10 a.m. to 8 a.m. to
9 a.m. The meeting is partially closed to
the public.
Dated: September 29, 2023.
Patricia B. Hansberger,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2023–22099 Filed 10–4–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Notice of Meeting for the
Interdepartmental Substance Use
Disorders Coordinating Committee
(ISUDCC)
Substance Abuse and Mental
Health Services Administration
(SAMHSA), Department of Health and
Human Services (HHS).
ACTION: Notice.
AGENCY:
The Secretary of Health and
Human Services (Secretary) announces
a meeting of the Interdepartmental
Substance Use Disorders Coordinating
Committee (ISUDCC). The ISUDCC is
open to the public and members of the
public can attend the meeting via
telephone or webcast only, and not in
person. Agenda with call-in information
will be posted on the SAMHSA website
prior to the meeting at: https://
www.samhsa.gov/about-us/advisorycouncils/meetings. The meeting will
include reports from the ISUDCC
Working Groups, and discussion of the
ISUDCC’s recommendations to HHS on
how the Federal Government can
further integrate and coordinate harm
reduction approaches and strategies
across the continuum of prevention,
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
18:37 Oct 04, 2023
Jkt 262001
treatment, and recovery policies,
programs, and practices.
DATES: December 6, 2023, 9 a.m.–12:30
p.m., ET/Open.
ADDRESSES: The meeting will be held
virtually, and can be accessed via Zoom.
FOR FURTHER INFORMATION CONTACT:
Tracy Goss, ISUDCC Designated Federal
Officer, Substance Abuse and Mental
Health Services Administration, 5600
Fishers Lane, Rockville, MD 20857;
telephone: 240–276–0759; email:
Tracy.Goss@samhsa.hhs.gov.
SUPPLEMENTARY INFORMATION:
Committee Name: Interdepartmental
Substance Use Disorders Coordinating
Committee (ISUDCC).
I. Background and Authority
The Interdepartmental Substance Use
Disorders Coordinating Committee is
required under section 7022 of the
Substance Use-Disorder Prevention that
Promotes Opioid Recovery and
Treatment for Patients and Communities
Act (SUPPORT Act, Pub. L. 115–271) to
accomplish the following duties: (1)
identify areas for improved coordination
of activities, if any, related to substance
use disorders, including research,
services, supports, and prevention
activities across all relevant Federal
agencies; (2) identify and provide to the
Secretary recommendations for
improving Federal programs for the
prevention and treatment of, and
recovery from, substance use disorders,
including by expanding access to
prevention, treatment, and recovery
services; (3) analyze substance use
disorder prevention and treatment
strategies in different regions of and
populations in the United States and
evaluate the extent to which Federal
substance use disorder prevention and
treatment strategies are aligned with
State and local substance use disorder
prevention and treatment strategies; (4)
make recommendations to the Secretary
regarding any appropriate changes with
respect to the activities and strategies
described in items (1) through (3) above;
(5) make recommendations to the
Secretary regarding public participation
in decisions relating to substance use
disorders and the process by which
public feedback can be better integrated
into such decisions; and (6) make
recommendations to ensure that
substance use disorder research,
services, supports, and prevention
activities of the Department of Health
and Human Services and other Federal
agencies are not unnecessarily
duplicative.
Not later than one year after the date
of the enactment of this Act, and
annually thereafter for the life of the
PO 00000
Frm 00099
Fmt 4703
Sfmt 4703
69213
Committee, the Committee shall publish
on the internet website of the
Department of Health and Human
Services, which may include the public
information dashboard established
under section 1711 of the Public Health
Service Act, as added by section 7021,
a report summarizing the activities
carried out by the Committee pursuant
to subsection (e), including any findings
resulting from such activities.
II. Membership
This ISUDCC consists of Federal
members listed below or their
designees, and non-Federal public
members.
Federal Membership: Members
include, The Secretary of Health and
Human Services; The Attorney General
of the United States; The Secretary of
Labor; The Secretary of Housing and
Urban Development; The Secretary of
Education; The Secretary of Veterans
Affairs; The Commissioner of Social
Security; The Assistant Secretary for
Mental Health and Substance Use; The
Director of National Drug Control
Policy; representatives of other Federal
agencies that support or conduct
activities or programs related to
substance use disorders, as determined
appropriate by the Secretary.
Non-Federal Membership: Members
include, 17 non-Federal public members
appointed by the Secretary, representing
individuals who have received
treatment for a diagnosis of a substance
use disorder; directors of State
substance use agencies; representatives
of leading research, advocacy, or service
organizations for adults with substance
use disorder; physicians, licensed
mental health professionals, advance
practice registered nurses, and
physician assistants, who have
experience in treating individuals with
substance use disorders; substance use
disorder treatment professionals who
provide treatment services at a certified
opioid treatment program; substance use
disorder treatment professionals who
have research or clinical experience in
working with racial and ethnic minority
populations; substance use disorder
treatment professionals who have
research or clinical mental health
experience in working with medically
underserved populations; State-certified
substance use disorder peer support
specialists; drug court judge or a judge
with experience in adjudicating cases
related to substance use disorder; public
safety officers with extensive experience
in interacting with adults with a
substance use disorder; and individuals
with experiences providing services for
homeless individuals with a substance
use disorder.
E:\FR\FM\05OCN1.SGM
05OCN1
]]>Agencies
[Federal Register Volume 88, Number 192 (Thursday, October 5, 2023)]
[Notices]
[Page 69213]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-22099]
[[Page 69213]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Amended Notice of
Meeting
Notice is hereby given of a change in the meeting of the National
Heart, Lung, and Blood Advisory Council, October 24, 2023, 9 a.m. to
October 24, 2023, 5 p.m., National Institutes of Health, Rockledge I,
6705 Rockledge Drive, Bethesda, MD 20892 which was published in the
Federal Register on September 14, 2023, FR Doc. 2023-19906, 88 FRN
63116.
This notice is being amended to change the meeting time for
National Heart, Lung, and Blood Advisory Council closed session on
October 24, 2023 from 9 a.m. to 10 a.m. to 8 a.m. to 9 a.m. The meeting
is partially closed to the public.
Dated: September 29, 2023.
Patricia B. Hansberger,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2023-22099 Filed 10-4-23; 8:45 am]
BILLING CODE 4140-01-P
